← Back to Search

Substance Use Brief Intervention for HIV/AIDS (Swerve Trial)

N/A
Waitlist Available
Led By Rob Stephenson, PhD
Research Sponsored by University of Michigan
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be younger than 65 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 18 months
Awards & highlights

Swerve Trial Summary

This study is evaluating whether a brief intervention can help people who are at risk for HIV to get tested and get into care.

Eligible Conditions
  • HIV/AIDS
  • Substance Abuse

Swerve Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~18 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 18 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Increases in repeat HIV testing
Other outcome measures
Decreased STI incidence
Decreases in sexual risk behavior
Increase in the number of participants who have been successfully engaged in care
+2 more

Swerve Trial Design

4Treatment groups
Experimental Treatment
Active Control
Group I: SUBI + SUBIExperimental Treatment1 Intervention
Participants will receive the SUBI at both visit 1 and visit 2.
Group II: SUBI + SOCExperimental Treatment2 Interventions
Participants will receive the SUBI at visit 1 and SOC at visit 2.
Group III: SOC + SUBIExperimental Treatment2 Interventions
Participants will receive SOC at visit 1 and the experimental substance use brief intervention (SUBI) at visit 2.
Group IV: SOC + SOCActive Control1 Intervention
Participants will receive current standard of care (SOC) for HIV counseling, testing, and referral at both visit 1 and visit 2.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Substance Use Brief Intervention
2017
N/A
~260
Standard of Care (SOC)
2017
Completed Phase 4
~2210

Find a Location

Who is running the clinical trial?

National Institute on Drug Abuse (NIDA)NIH
2,464 Previous Clinical Trials
2,618,335 Total Patients Enrolled
University of MichiganLead Sponsor
1,794 Previous Clinical Trials
6,373,658 Total Patients Enrolled
Rob Stephenson, PhDPrincipal InvestigatorDirector, Professor
4 Previous Clinical Trials
2,068 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Recent research and studies
clinicaltrials.govStudy
Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use Intervention
Robert Stephenson 2017. "Optimizing HIV Counseling and Testing and Referral Through an Adaptive Drug Use Intervention". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT02945436.
~32 spots leftby Apr 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top